RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: An immunocytochemical study

European Journal of Histochemistry

Volumn 53, Issue 3, 2009, Pages 151-158

  Perdoni, F ^a   Malatesta, M ^b   Cardani, R ^c   Giagnacovo, M ^c   Mancinelli, E ^c   Meola, G ^c   Pellicciari, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Electron microscopy; Fluorescence microscopy; Immunocytochemistry; Myoblast; Myotonic dystrophy type 2 DM2; RNA processing

Indexed keywords

ANTIBODY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA PRECURSOR; MUSCLEBLIND LIKE 1 PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RNA; RNA BINDING PROTEIN; RNA POLYMERASE II; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MYOBLAST; MYOTONIC DYSTROPHY; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION; TRANSMISSION ELECTRON MICROSCOPY;

CELL NUCLEUS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; MYOBLASTS; MYOTONIC DYSTROPHY; RNA; RNA-BINDING PROTEINS;

EID: 70849130776     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2009.e18     Document Type: Article

References (38)

1. Bernhard W. A new staining procedure for electron microscopic cytology. J Ultrastruct Res 1969;27:250-265
2. Biggiogera M, Bottone MG, Scovassi AI, Soldani C,Vecchio L,Pellicciari C. Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest. Biol Cell 2004;96:603-615
3. Biggiogera M, Cisterna B, Spedito A, Vecchio L, Malatesta M. Perichromatin fibrils as early markers of transcriptional alterations. Differentiation 2007;76:57-65.
4. Biggiogera M., Bottone M.G., Pellicciari C. Nuclear RNA is extruded from apoptotic cells. J Histochem Cytochem 1998;46:999-1006.
5. Biggiogera M., Pellicciari C. Heterogeneous Ectopic RNP-Derived Structures (HERDS) are markers of transcriptional arrest. FASEB J 2000;14:828-834 (Pubitemid 30198582)
6. Cardani R, Baldassa S, Botta A, Rinaldi F, Novelli G, Mancinelli E, et al. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2. Neuromuscul Disord 2009;19:335-343
7. Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 2006;50:177-182
8. Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 2004;48:437-442
9. Dere R, Napierala M,Ranum LPW,Wells RD. Hairpin structure-forming property of the (CCTG-CAGG) tetranucletide repeats contributes to the genetic instability associated with myotonic dystrophy type 2. J Biol Chem 2004;279:41715-41726 (Pubitemid 39313617)
10. Fakan S. Ultrastructural cytochemical analyses of nuclear functional architecture. Eur J Histochem 2004;48:5-14. (Pubitemid 38524331)
11. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, et al. Three proteins , MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Gen 2002;11:805-814 (Pubitemid 34428648)
12. Holt I, Mittal S, Furling D, Butler-Browne GS, Brook JD, Morris GE. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells 2007;12:1035-1048 (Pubitemid 47365675)
13. Jiang H, Mankodi A, Swanson MS, Moxley RT,Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Gen 2004;13:3079-3088 (Pubitemid 40045262)
14. Jones RE, Okamura CS, Martin TE. Immunofluorescent localization of the proteins of nuclear ribonucleoprotein complexes. J Cell Biol 1980;86:235-243
15. Junghans RP. Dystrophya myotonia: why focus on foci? Eur J Hum Gen 2009;17:543-553
16. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867
17. Malatesta M, Cardinali A, Battistelli S, Zancanaro C, Martin TE, Fakan S, et al. Nuclear bodies are usual constituents in tissues of hibernating dormice. Anat Rec 1999;254:389-395 (Pubitemid 29122252)
18. Malatesta M, Frigato E, Baldelli B, Battistelli S, Foà A, Bertolucci C. Influence of temperature on the liver circadian clock in the ruin lizard Podarcis sicula. Microsc Res Tech 2007;70:578-584 (Pubitemid 47047882)
19. Malatesta M, Luchetti F, Marcheggiani F, Fakan S, Gazzanelli G. Disassembly of nuclear bodies during arousal from hibernation: an in vitro study. Chromosoma 2001;110:471-477 (Pubitemid 34007378)
20. Malatesta M, Zancanaro C,Martin TE, Chan EKL, Amalric F, Lührmann R, et al. Cytochemical and immunocytochemical characterization of nuclear bodies during hibernation. Eur J Cell Biol 1994;65:82-93. (Pubitemid 24328180)
21. Mankodi A,Lin XL, Blaxal BC,Swanson MS,Thornton CA.Nuclear RNA foci in the heart in myotonic dystrophy. Circ Res 2005;97:1152-1155
22. Mankodi A,Takahashi MP, Jiang H, Beck CL, Bowers WJ,Moxley RT, et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002;10:35-44. (Pubitemid 34879147)
23. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 2003;54:760-768 (Pubitemid 37498959)
24. Mankodi A, Urbinati CR,Yuan QP, Moxley RT, Sansone V, Krym M, et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001;10:2165-2170
25. Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LP. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 2006;15:1808-1815
26. Moxley 3rd RT, Meola G, Udd B, Ricker K. Report of the 84th ENMC workshop:PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October 2000, Loosdrecht:The Netherlands. Neuromuscul Disord 2002;12:306-317
27. Osborne RJ, Thornton CA. RNA-dominant diseases. Hum Mol Genet 2006;15:R162-9.
28. Pascual M,Vicente M, Monferrer L, Artero R.The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006;74:65-80. (Pubitemid 43376167)
29. Puvion E, Puvion-Dutilleul F. Ultrastructure of the nucleus in relation to transcription and splicing: roles of perichromatin fibrils and interchromatin granules. Exp Cell Res 1996;229:217-225 (Pubitemid 27026908)
30. Ranum LPW, Day JW. Myotonic Dystrophy: RNA Pathogenesis Comes into Focus. Am Jf Hum Genetics, 200474:793-804
31. Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006;29:259-277
32. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004;74:1309-1313
33. Schoser BGH, Ricker K, Schneider-Gold C, Hengstenberg C, Dürre J, Bültmann B, et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004;63:2402-2404 (Pubitemid 40024362)
34. Spector DL. Nuclear organization and gene expression. Exp Cell Res 1996;229:189-197
35. Taneja KL, McCurrach M, Schalling M, Housmann D, Singer RH. Foci of trinucleotide repeats in nuclei of myotonic dystrophy cells and tissue. J Cell Biol 1995;128:995-1002.
36. Veraldi KL, Arhin GK, Martincic K, Chung-Ganster LH, Wilusz J, Milcarek C. HnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol 2001;21:1228-1238 (Pubitemid 32114971)
37. Wheeler TM, Krym MC,Thornton CA. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. Neuromuscul Disord 2007;17:242-247 (Pubitemid 46413760)
38. Wheeler TM,Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 2007;20:572-576